Capecitabine/irinotecan or capecitabine/oxaliplatin in...

Annals of Oncology 2013 / 06 Vol. 24; Iss. 6

Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group

Schmiegel, W., Reinacher-Schick, A., Arnold, D., Kubicka, S., Freier, W., Dietrich, G., Geissler, M., Hegewisch-Becker, S., Tannapfel, A., Pohl, M., Hinke, A., Schmoll, H. J., Graeven, U.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt028
Date:
June, 2013
File:
PDF, 188 KB
english, 2013
Conversion to is in progress
Conversion to is failed